SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001179110-04-016640
Filing Date
2004-08-17
Accepted
2004-08-17 13:33:11
Documents
2
Period of Report
2004-08-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 - edgar.html 3  
1 FORM 3 - edgar.xml 3 2673
2 POWER OF ATTORNEY ex24tcooke.txt EX-24 2914
  Complete submission text file 0001179110-04-016640.txt   7538
Mailing Address 119 FOURTH AVE NEEDHAM MA 021942725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
AVANT IMMUNOTHERAPEUTICS INC (Issuer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 910 WEST END AVENUE, APT.9B NEW YORK NY 10025
Business Address 781-433-3114
Cooke Michael Timothy (Reporting) CIK: 0001300653 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-15006 | Film No.: 04981348